Marina Bralic1, Matija Sosic2, Slavica Kovacic3, Vladimira Vuletic2. 1. Department of Neurology, Clinical Hospital Centre Rijeka, Kresimirova 42, 51 000, Rijeka, Croatia. marina.bralic@yahoo.com. 2. Department of Neurology, Clinical Hospital Centre Rijeka, Kresimirova 42, 51 000, Rijeka, Croatia. 3. Department of Radiology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
Abstract
BACKGROUND: Acute ischemic stroke (AIS) has a high risk of recurrence, particularly in the early stage. Recurrent ischemic stroke (RIS) is associated with adverse neurological outcomes but the phenomenon of early RIS in the endovascular thrombectomy era has not been frequently discussed. We report a case addressing this issue. CASE PRESENTATION: We present a patient who was successfully treated by mechanical thrombectomy (MT) for middle cerebral artery occlusion. Due to an early stroke recurrence, within 72 h after the first MT, he received systemic thrombolysis and repeated MT was performed with excellent clinical outcome. DISCUSSION: We discuss the aspects of reperfusion therapy for patients experiencing early stroke recurrence. Consideration was given to stroke etiology and off-label use of thrombolytic therapy. Also, effectiveness of repeated MT for early re-occlusion of initially reanalyzed vessel was evaluated in order to allow more patients with RIS to benefit from reperfusion therapy.
BACKGROUND: Acute ischemic stroke (AIS) has a high risk of recurrence, particularly in the early stage. Recurrent ischemic stroke (RIS) is associated with adverse neurological outcomes but the phenomenon of early RIS in the endovascular thrombectomy era has not been frequently discussed. We report a case addressing this issue. CASE PRESENTATION: We present a patient who was successfully treated by mechanical thrombectomy (MT) for middle cerebral artery occlusion. Due to an early stroke recurrence, within 72 h after the first MT, he received systemic thrombolysis and repeated MT was performed with excellent clinical outcome. DISCUSSION: We discuss the aspects of reperfusion therapy for patients experiencing early stroke recurrence. Consideration was given to stroke etiology and off-label use of thrombolytic therapy. Also, effectiveness of repeated MT for early re-occlusion of initially reanalyzed vessel was evaluated in order to allow more patients with RIS to benefit from reperfusion therapy.
Authors: Mehdi Bouslama; Diogo C Haussen; Leticia C Rebello; Jonathan A Grossberg; Michael R Frankel; Raul G Nogueira Journal: Interv Neurol Date: 2016-09-09
Authors: B Gory; D Bresson; I Kessler; M L Perrin; A Guillaudeau; K Durand; S Ponsonnard; C Couquet; C Yardin; C Mounayer Journal: AJNR Am J Neuroradiol Date: 2013-03-28 Impact factor: 3.825
Authors: Robert Joseph Cruz Sarmiento; Jose Danilo Bengzon Diestro; Adrian Isidoro Espiritu; Maria Cristina Zarsadias San Jose Journal: J Stroke Cerebrovasc Dis Date: 2019-07-29 Impact factor: 2.136
Authors: Pascal J Mosimann; Johannes Kaesmacher; Dominic Gautschi; Sebastian Bellwald; Leonidas Panos; Eike Piechowiak; Tomas Dobrocky; Felix Zibold; Pasquale Mordasini; Marwan El-Koussy; Roland Wiest; David Bervini; Franca Wagner; Marcel Arnold; Simon Jung; Aikaterini Galimanis; Jan Gralla; Urs Fischer Journal: Stroke Date: 2018-11 Impact factor: 7.914
Authors: Frans Kauw; Richard A P Takx; Hugo W A M de Jong; Birgitta K Velthuis; L Jaap Kappelle; Jan W Dankbaar Journal: Cerebrovasc Dis Date: 2018-06-22 Impact factor: 2.762